Lara leads Quant’s daily operations, strategy, and administration as it goes to market internationally. 

Lara brings over 20 years’ experience in the Healthcare and Lifesciences industry as a specialist in the development of global pricing and GTM (Go-To-Market) strategies for pharma companies. Having held senior positions in international leadership, she has a strong track record of success in global launches, pricing strategies and played key roles in valuation and due diligence projects relating to acquisition targets, both of pharmaceutical companies and private equity.

Highly experienced in business development and managing multimillion dollar budgets, Lara successfully led the pharmaceutical and life sciences division of the broader Health Economics and Social Policy Practice at Deloitte, and has worked at other leading pharmaceutical/healthcare brands, including J&J, Pfizer, GSK, Eisai, Actelion and Intercept.

She holds an MBA from the University of Technology Sydney, and an MSc in Health Economics from London School of Economics and Political Science.